http://rdf.ncbi.nlm.nih.gov/pubchem/reference/13606491

Outgoing Links

Predicate Object
contentType Journal Article|Meta-Analysis|Systematic Review
endingPage 5599
issn 2224-5839
2224-5820
issueIdentifier 5
pageRange 5590-5599
publicationName Annals of Palliative Medicine
startingPage 5590
bibliographicCitation Yang L, Xue J, Yang Z, Wang M, Yang P, Dong Y, He X, Bao G, Peng S. Side effects of CDK4/6 inhibitors in the treatment of HR+/HER2- advanced breast cancer: a systematic review and meta-analysis of randomized controlled trials. Ann Palliat Med. 2021 May;10(5):5590–9. doi: 10.21037/apm-21-1096. PMID: 34107710.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_94ae7dbeae526a56fe7f2c90b0e8cf80
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1b6182f59d696d778631f18b8840fa72
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1b3223888fd232a23476b82498b218d4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a2d9e9c19cc6ac5bbe6700b8b5a47bd0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f749cfdca0d90dd1b6d4e4932dc98ecc
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e1871d82540f8ca48fdf5896f91d7983
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d9c91ab1095c1cf0ed34acbe3b395394
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a265018be0a630a288cae941ddbed6c8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cfe5cb30535b0200041613b71c6ac5a8
date 202105
identifier https://pubmed.ncbi.nlm.nih.gov/34107710
https://doi.org/10.21037/apm-21-1096
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/40347
https://portal.issn.org/resource/ISSN/2224-5839
https://portal.issn.org/resource/ISSN/2224-5820
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Side effects of CDK4/6 inhibitors in the treatment of HR+/HER2− advanced breast cancer: a systematic review and meta-analysis of randomized controlled trials
discusses http://id.nlm.nih.gov/mesh/M0018586
http://id.nlm.nih.gov/mesh/M0228003
http://id.nlm.nih.gov/mesh/M0208277
http://id.nlm.nih.gov/mesh/M0028048
http://id.nlm.nih.gov/mesh/M0474139
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D001943Q000188
http://id.nlm.nih.gov/mesh/D051361
hasSubjectTerm http://id.nlm.nih.gov/mesh/D016032
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D018719
http://id.nlm.nih.gov/mesh/D051358
http://id.nlm.nih.gov/mesh/D011960
http://id.nlm.nih.gov/mesh/D005260
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9408
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_562c8631efeaf61a73a4206ef1b58061
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7706
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID108157
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_43830973f74de180729ad1e755d592ad
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_e8ad08f759b2798c1b5dca78861cc6ce
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11445
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_2.6.1.2
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6873
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7453
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_aeebd1980c6662678028fc899ba441eb
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_bbdfbd9125c9548c7427fed47668c508
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8593
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8321
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8661

Total number of triples: 57.